Want to see HK:8106 full AI Analyst Report?
Shenghua Lande Scitech Limited Class H (8106) Ratios
Shenghua Lande Scitech Limited Class H Ratios
HK:8106's free cash flow for Q2 2026 was $-13.49M. For the 2026 fiscal year, HK:8106's free cash flow was increased by $0.00 and operating cash flow was $-13.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.68 | 1.73 | 2.51 | 4.09 | 2.42 |
| Quick Ratio | 1.48 | 1.63 | 1.99 | 3.82 | 2.25 |
| Cash Ratio | 0.36 | 0.25 | 0.47 | 0.84 | 0.64 |
| Solvency Ratio | 0.02 | -0.09 | -1.27 | -0.41 | 0.02 |
| Operating Cash Flow Ratio | 0.07 | -0.26 | -0.82 | -1.40 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 0.14 | -0.57 | -2.26 | -3.81 | 0.01 |
| Net Current Asset Value | $ 46.74M | $ 45.52M | $ 49.73M | $ 84.32M | $ 88.16M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.26 | 0.14 | 0.08 | 0.09 |
| Debt-to-Equity Ratio | 0.72 | 0.60 | 0.22 | 0.10 | 0.14 |
| Debt-to-Capital Ratio | 0.42 | 0.38 | 0.18 | 0.09 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.43 | 2.31 | 1.61 | 1.28 | 1.55 |
| Debt Service Coverage Ratio | 0.07 | -0.17 | -3.37 | -1.33 | 0.97 |
| Interest Coverage Ratio | 7.15 | -0.74 | -66.15 | -58.78 | 87.55 |
| Debt to Market Cap | 0.25 | 0.76 | 0.33 | 0.19 | 0.13 |
| Interest Debt Per Share | 0.07 | 0.06 | 0.02 | 0.02 | 0.03 |
| Net Debt to EBITDA | 2.00 | -2.78 | 0.08 | 0.94 | -2.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.80% | 11.26% | 11.74% | 11.66% | 19.30% |
| EBIT Margin | 1.87% | -2.96% | -42.55% | -13.98% | 3.75% |
| EBITDA Margin | 2.13% | -2.58% | -41.57% | -10.31% | 4.25% |
| Operating Profit Margin | 2.86% | -0.27% | -23.81% | -13.10% | 3.10% |
| Pretax Profit Margin | 1.50% | -3.33% | -42.91% | -14.20% | 4.11% |
| Net Profit Margin | 0.47% | -3.52% | -43.61% | -11.97% | 0.32% |
| Continuous Operations Profit Margin | 0.47% | -3.52% | -43.61% | -14.08% | 3.66% |
| Net Income Per EBT | 31.57% | 105.55% | 101.62% | 84.31% | 7.85% |
| EBT Per EBIT | 52.37% | 1225.45% | 180.25% | 108.39% | 132.59% |
| Return on Assets (ROA) | 0.91% | -5.91% | -49.08% | -13.01% | 0.38% |
| Return on Equity (ROE) | 2.22% | -13.63% | -78.86% | -16.67% | 0.59% |
| Return on Capital Employed (ROCE) | 13.36% | -1.05% | -43.05% | -18.24% | 5.80% |
| Return on Invested Capital (ROIC) | 2.47% | -0.66% | -35.27% | -16.39% | 4.68% |
| Return on Tangible Assets | 0.91% | -5.91% | -49.08% | -13.21% | 0.38% |
| Earnings Yield | 0.77% | -17.09% | -117.96% | -31.43% | 1.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.15 | 2.15 | 2.20 | 2.31 | 3.05 |
| Payables Turnover | 8.94 | 6.32 | 5.57 | 9.87 | 6.82 |
| Inventory Turnover | 15.12 | 26.72 | 5.06 | 16.35 | 15.98 |
| Fixed Asset Turnover | 120.50 | 96.08 | 36.88 | 44.53 | 15.10 |
| Asset Turnover | 1.94 | 1.68 | 1.13 | 1.09 | 1.17 |
| Working Capital Turnover Ratio | 4.97 | 3.89 | 1.46 | 1.52 | 2.15 |
| Cash Conversion Cycle | 99.23 | 125.97 | 172.80 | 143.53 | 88.94 |
| Days of Sales Outstanding | 115.92 | 170.02 | 166.18 | 158.18 | 119.58 |
| Days of Inventory Outstanding | 24.14 | 13.66 | 72.12 | 22.32 | 22.85 |
| Days of Payables Outstanding | 40.83 | 57.71 | 65.50 | 36.98 | 53.48 |
| Operating Cycle | 140.06 | 183.68 | 238.30 | 180.51 | 142.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | -0.03 | -0.05 | -0.08 | 0.00 |
| Free Cash Flow Per Share | 0.01 | -0.03 | -0.06 | -0.08 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 437.55 | -1644.70 | -31.75 | -12.97 | 0.01 |
| Capital Expenditure Coverage Ratio | 437.55 | -1644.70 | -31.75 | -12.97 | 0.01 |
| Operating Cash Flow Coverage Ratio | 0.14 | -0.57 | -2.26 | -3.81 | 0.01 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.09 | -0.28 | -0.28 | 0.00 |
| Free Cash Flow Yield | 3.40% | -43.24% | -77.05% | -79.88% | -9.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 132.59 | -5.85 | -0.85 | -3.18 | 95.53 |
| Price-to-Sales (P/S) Ratio | 0.61 | 0.21 | 0.37 | 0.38 | 0.31 |
| Price-to-Book (P/B) Ratio | 2.88 | 0.80 | 0.67 | 0.53 | 0.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 29.37 | -2.31 | -1.30 | -1.25 | -11.11 |
| Price-to-Operating Cash Flow Ratio | 29.30 | -2.31 | -1.34 | -1.35 | 774.75 |
| Price-to-Earnings Growth (PEG) Ratio | -1.14 | 0.07 | -0.01 | 0.01 | 3.49 |
| Enterprise Value Multiple | 30.80 | -10.76 | -0.81 | -2.76 | 4.32 |
| Enterprise Value | 150.84M | 51.29M | 32.91M | 38.42M | 37.81M |
| EV to EBITDA | 30.80 | -10.76 | -0.81 | -2.76 | 4.32 |
| EV to Sales | 0.66 | 0.28 | 0.34 | 0.28 | 0.18 |
| EV to Free Cash Flow | 31.41 | -3.12 | -1.18 | -0.93 | -6.61 |
| EV to Operating Cash Flow | 31.34 | -3.12 | -1.22 | -1.01 | 461.07 |
| Tangible Book Value Per Share | 0.10 | 0.09 | 0.11 | 0.19 | 0.20 |
| Shareholders’ Equity Per Share | 0.10 | 0.09 | 0.11 | 0.19 | 0.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.68 | -0.06 | -0.02 | 0.01 | 0.11 |
| Revenue Per Share | 0.45 | 0.37 | 0.19 | 0.27 | 0.41 |
| Net Income Per Share | 0.00 | -0.01 | -0.08 | -0.03 | 0.00 |
| Tax Burden | 0.32 | 1.06 | 1.02 | 0.84 | 0.08 |
| Interest Burden | 0.80 | 1.12 | 1.01 | 1.02 | 1.10 |
| Research & Development to Revenue | 0.01 | 0.02 | 0.13 | 0.07 | 0.04 |
| SG&A to Revenue | 0.08 | 0.09 | 0.15 | 0.13 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.40 | 2.67 | 0.64 | 1.07 | -0.01 |
Currency in CNY